Modification of CRISPR guide RNA structure prevents immune response in target cells

Modification of CRISPR guide RNA structure prevents immune response in target cells
In vitro transcribed-CRISPR guide RNAs trigger innate immune response in cells, but can be prevented by removing the triphosphate moiety. Credit: Sojung Kim

CRISPR-mediated genome editing has become a powerful tool for modeling of disease in various organisms and is being developed for clinical applications. Preassembled Cas9 ribonucleoproteins (RNPs) composed of the recombinant Cas9 protein and in vitrotranscribed (IVT) guide RNA complexes can be delivered into cells without risk of foreign DNA integration into the host genome and with fewer off-target effects. However, in a study published today in Genome Research, scientists discovered in vitro-transcribed gRNAs, containing a 5' triphosphate (5'ppp) moiety, activate the immune response in human cells leading to cell death.

"CRISPR-Cas9 RNPs are now broadly used in biomedical research and hold promise in therapeutic " says corresponding author Jin-Soo Kim from the Institute for Basic Science (Seoul, South Korea). Thus, translation of this technology from biomedical applications to clinical applications requires a thorough investigation into potentially deleterious host responses.

In this study, researchers generated and transfected IVT gRNAs complexed with purified Cas9, into human cervical cancer cells (HeLa) and mouse embryonic fibroblasts. In these cells, 5'ppp gRNAs elicited a type I interferon-mediated immune response, as well as increased expression of interferon-activated antiviral effector proteins, such as DDX58, resulting in cell death.

Additionally, this study demonstrates the of 5'ppp gRNA on human T cells. "Genome editing in T cells holds great promise in cell therapy for the treatment of cancer and HIV infection. T were extremely sensitive to the 5' triphosphate group in gRNAs" says Kim. The T cell surface receptor, CCR5, is involved in HIV virus entry and is therefore a promising target for anti-HIV therapies. Kim et al. demonstrated that pretreatment of IVT gRNAs with phosphatase, removes the 5'ppp and significantly reduces T cell host immune response and cytotoxicity. Phosphatase treated IVT gRNAs displayed increased mutation efficiency against CCR5 resulting in significantly decreased cell surface presentation of this HIV coreceptor.

This research elucidates the cytotoxic effects on by immune activating IVT gRNAs in CRISPR-Cas9 or Cpf1 ribonucleoprotein complexes and offers a new method to prevent host , while maintaining high mutation efficiency, toward the effective therapeutic application of CRISPR-mediated genome editing.


Explore further

New techniques improve specificity of CRISPR/Cas9 genome editing tools

More information: Kim S, Koo T, Jee H, Cho H, Lee G, Lim D, Shik Shin H, and Kim J. 2018. CRISPR RNAs trigger innate immune responses in human cells. Genome Res , DOI: 10.1101/gr.231936.117
Journal information: Genome Research

Provided by Cold Spring Harbor Laboratory Press
Citation: Modification of CRISPR guide RNA structure prevents immune response in target cells (2018, February 22) retrieved 13 November 2019 from https://phys.org/news/2018-02-modification-crispr-rna-immune-response.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
58 shares

Feedback to editors

User comments